Patterns of health care resource utilization after macrolide treatment failure: Results from a large, population-based cohort with acute sinusitis, acute bronchitis, and community-acquired pneumonia

Clinical Therapeutics

Volumn 26, Issue 12, 2004, Pages 2153-2162

  Wu, Jasmanda H ^a   Howard, David H ^b   McGowan Jr , John E ^b   Frau, Lourdes M ^a   Dai, Wanju S ^a  

^a SANOFI   (France)

^b EMORY UNIVERSITY   (United States)

Author keywords

Acute bronchitis; Acute sinusitis; Community acquired pneumonia; Macrolide treatment failure; Respiratory infection

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZITHROMYCIN; CEPHALOSPORIN; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BRONCHITIS; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; FEMALE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POISSON DISTRIBUTION; POPULATION RESEARCH; RESPIRATORY TRACT INFECTION; SINUSITIS; TREATMENT FAILURE;

EID: 14844364044     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2004.12.016     Document Type: Article

References (25)

1. Advance Data from Vital and Health Statistics, No. 337 Cherry DK, Burt CW, and Woodwell DA National Ambulatory Medicare Care Survey: 2001 Summary 2003 National Center for Health Statistics New York
2. Advance Data from Vital and Health Statistics, No. 338 Hing E, and Middleton K National Hospital Ambulatory Medical Care Survey: 2001 Outpatient Department Summary 2003 National Center for Health Statistics Hyattsville, Md
3. Advance Data from Vital and Health Statistics, No. 335 McCaig LF, and Burt CW National Hospital Ambulatory Medical Care Survey: 2001 Emergency Department Summary 2003 National Center for Health Statistics Hyattsville, Md
4. International Classification of Diseases, Ninth Revision, Clinical Modification 6th ed 2003 US Dept of Health and Human Services, Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services Hyattsville, Md
5. Advance Data from Vital and Health Statistics, No. 342 DeFrances CJ, and Hall MJ 2002 National Hospital Discharge Survey 2004 National Center for Health Statistics Washington, DC
6. Bartlett JG, Dowell SF, and Mandell LA Infectious Diseases Society of America Practice guidelines for the management of community-acquired pneumonia in adults Clin Infect Dis. 31 2000 347 382
7. Sande MA, and Gwaltney JM Acute community-acquired bacterial sinusitis: Continuing challenges and current management Clin Infect Dis. 39 Suppl 3 2004 S151 S158
8. Piccirillo JE Clinical practice. Acute bacterial sinusitis N Engl J Med. 351 2004 902 910
9. Mandell LA, Bartlett JG, and Dowell SF Infectious Diseases Society of America Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults Clin Infect Dis. 37 2003 1405 1433
10. Doern GV, Heilmann KP, and Huynh HK Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995 Antimicrob Agents Chemother. 45 2001 1721 1729
11. Gay K, Baughman W, and Miller Y The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: A 6-year population-based assessment J Infect Dis. 182 2000 1417 1424
12. Hoban DJ, Doern GV, and Fluit AC Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999 Clin Infect Dis. 32 Suppl 2 2001 S81 S93
13. Hyde TB, Gay K, and Stephens DS Active Bacterial Core Surveillance/Emerging Infections Macrolide resistance among invasive Streptococcus pneumoniae isolates JAMA 286 2001 1857 1862
14. Lynch JP III, and Martinez FJ Clinical relevance of macrolide-resistan Streptococcus pneumoniae for community-acquired pneumonia Clin Infect Dis. 34 Suppl 1 2002 S27 S46
15. Perez-Trallero E, Fernandez-Mazarrasa C, Garcia-Rey C Spanish Surveillance Group for Respiratory Pathogens Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: Results of a 1-year (1998-1999) multicenter surveillance study in Spain Antimicrob Agents Chemother. 45 2001 3334 3340
16. Thornsberry C, Sahm DF, and Kelly LJ Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST Surveillance Program, 1999-2000 Clin Infect Dis. 34 Suppl 1 2002 S4 S16
17. Berman S, Byrns PJ, and Bondy J Otitis media-related antibiotic prescribing patterns, outcomes, and expenditures in a pediatric Medicaid population Pediatrics 100 1997 585 592
18. Bjerrum L, Dessau RB, and Hallas J Treatment failures after antibiotic therapy of uncomplicated urinary tract infections. A prescription database study Scand J Prim Health Care 20 2002 97 101
19. Hueston WJ, Mainous AG III, and Ornstein S Antibiotics for upper respiratory tract infections. Follow-up utilization and antibiotic use Arch Fam Med. 8 1999 426 430
20. Piccirillo JF, Mager DE, and Frisse ME Impact of first-line vs second-line antibiotics for the treatment of acute uncomplicated sinusitis JAMA 286 2001 1849 1856
21. Howard DH, and McGowan JE Jr Initial and follow-up costs by treatment outcome for children with respiratory infections Pediatrics. 113 2004 1352 1356
22. Ellison SF, Cockburn I, Griliches Z, and Hausman J Characteristics of demand for pharmaceutical products: An examination of four cephalosporins Rand J Econ. 28 1997 426 446
23. Health Insurance Portability and Accountability Act of 1996, 42 USC §1320-d2.
24. Drug Topics Red Book 2002 Thomson Medical Economics Hyattsville, Md
25. Fine MJ, Stone RA, and Singer DE Processes and outcomes of care for patients with community-acquired pneumonia: Results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study Arch Intern Med. 159 1999 970 980